An NSF International Company

Industry news

NSF Health Sciences experts bring you the latest news updates from the industry

QP’s Declaration of GMP Compliance for Investigational Medical Products

Friday the 3rd May 2013

On 30 April 2025 the European Commission published the final version of a ‘Template for the QP’s Declaration of GMP Compliance for IMPs manufactured in non-EU countries’ as an addition to Eudralex volume 10.

This is a simple two page template. The declaration can be made on the basis of either (i) an audit by the QP, where you have to say who the ‘auditing party’ was and the date of the last audit; or (ii) if the manufacturing site has not been audited, a justification as to how the QP knows that the site meets EU GMP.

    Quick links

    NSF Health Sciences have offices in Kirkbymoorside and Sheffield, UK and Washington and Ann Arbor, USA

    A word from NSF Health Sciences

    The legislation and guidance that apply to the healthcare industries is forever changing. NSF Health Sciences will provide you with regular updates on what is new and will also provide you with expert interpretation of these changes - what they mean

    Peter Gough

    © NSF Health Sciences 2015

    Registered Office: NSF Health Sciences, The Georgian House, 22/24 West End, Kirkbymoorside, York, UK, YO62 6AF
    Registered in England and Wales No: 3432550 | Tel: +44(0)1751 432999 | Fax: +44(0)1751 432450 | Email: [email protected]
    US Office: NSF Health Sciences, 2001 Pennsylvania Ave, NW, Suite 950, Washington DC 20006 | Tel: 1-202-822-1850 | Fax: 1-202-822-1859 | Email: [email protected]